Viewpoint: Nigeria is on the cusp of an agricultural genetic modification revolution. Here’s why patent protections are so crucial

The intersection of intellectual property (IP) and genomics is reshaping the landscape of healthcare, biotechnology, and business in Nigeria. Genomics—the study of an organism’s entire genetic material—has profound implications for medical research, personalised medicine, agriculture, and pharmaceutical innovations.

Genomic innovations involve vast amounts of research, making patents, copyrights, and trade secrets crucial in protecting discoveries. IP rights grant exclusive control over genetic sequencing techniques, diagnostic tools, and biopharmaceutical products, encouraging investment in research and development (R&D).

1. Patents: Patent law plays a central role in protecting biotechnological inventions, including genetic modifications and DNA-based diagnostics. The Nigerian Patents and Designs Act (Cap P2 LFN 2004) governs patent applications, requiring novelty, inventive steps, and industrial applicability.

…

Related on the SLP

U.S. Department of Health and Human Services Report on Pediatric Gender Dysphoria and Gender Conversion Efforts Viewpoint: Why Washington should sharply increase funding for intensive agricultural to address climate change, spur sustainability

Viewpoint: Dubious environmental fears: Why the AI buildout is critical to America’s ecological future

Vitamin D, omega-3 fish oil and glucosamine supplements could cause brain damage 

Child-monitoring apps: When the cure is worse than the harm—and how the technology could be tweaked

A thriving genomics industry will stimulate job creation across biotech startups, research institutions, and regulatory agencies. Moreover, international collaborations in genomic research can attract foreign direct investment (FDI) into Nigeria’s health and technology sectors.

This is an excerpt. Read the original post here